Steris | STE - Ebitda



Steris reported $353.78M in EBITDA for its fiscal quarter ending in March of 2025.


Ebitda Change Date
3M USD 1.45B 480M Jun/2025
Avanos Medical USD -63900000 85.5M Jun/2025
Baxter International USD 325M 251M Mar/2025
Becton, Dickinson and Co. USD 1.47B 81M Jun/2025
Boston Scientific USD 1.36B 16M Mar/2025
CONMED USD 56.31M 16.81M Jun/2025
Cooper Companies USD 272.7M 5.8M Jul/2025
Dexcom USD 308.8M 115.1M Jun/2025
Ecolab USD 978.9M 160.2M Jun/2025
Edwards Lifesciences USD 411.3M 15.3M Mar/2025
Fortive USD 288M 80.5M Jun/2025
Getinge SEK 3.47B 2.13B Dec/2024
Globus Medical USD 208.68M 44.48M Jun/2025
Haemonetics USD 106.31M 6.77M Jun/2025
Hologic USD 334M 26.7M Jun/2025
Idexx Laboratories USD 409.44M 58.85M Jun/2025
Insulet USD 157.5M 47M Jun/2025
Integra LifeSciences USD -472218000 536.09M Jun/2025
Intuitive Surgical USD 898.7M 317.2M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Masimo USD 72M 17.3M Jun/2025
Olympus JPY 32.57B 38.11B Jun/2025
Owens Minor USD 96.6M 12.17M Jun/2025
ResMed USD 540.03M 61.85M Jun/2025
Steris USD 353.78M 33.81M Mar/2025
Stryker USD 1.46B 49M Jun/2025
Tandem Diabetes Care USD -1851000 28.33M Jun/2025
Teleflex USD 222.67M 27.85M Jun/2025
Thermo Fisher Scientific USD 3.06B 541M Jun/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025